文献速递炎症性肠病

白细胞介素21驱动慢性肠道炎症中调节性T细胞的高代谢状态及CD4+ T细胞相关致病性

Interleukin 21 Drives a Hypermetabolic State and CD4+ T-Cell-Associated Pathogenicity in Chronic Intestinal Inflammation.
PubMed 文献 · Gastroenterology · 2024-01-23

研究探讨调节性T细胞(Tregs)代谢在肠道稳态中的作用,发现线粒体-内质网接触位点丰富,IL21减少该接触位点并增强GSK3β酶功能,导致高代谢状态和Treg炎症反应。抑制IL21诱导的代谢可减轻CD4+ T细胞驱动的慢性肠道炎症。

要点

  • Tregs中线粒体-内质网接触位点丰富,VDAC1抑制扰动丙酮酸代谢。
  • IL21减少线粒体-内质网接触位点,增强GSK3β功能,诱导Treg高代谢和炎症反应。
  • IL21诱导的代谢基因在人类克罗恩病肠道Tregs中富集。

核心结论

  • IL21触发与Treg炎症反应相关的代谢功能障碍。
  • 抑制Treg中IL21诱导的代谢可能减轻CD4+ T细胞驱动的慢性肠道炎症。

研究设计与样本

  • 使用人类Tregs进行线粒体超微结构、生化、蛋白质、代谢组学、基因表达和实时代谢分析。
  • 利用克罗恩病单细胞RNA测序数据集推断靶向代谢通路的治疗相关性。
  • 在CD4+ T细胞诱导的小鼠结肠炎模型中检查基因修饰Tregs的功能。

主要发现

  • 线粒体-内质网接触位点通过VDAC1介导丙酮酸进入线粒体,在Tregs中丰富。
  • VDAC1抑制扰动丙酮酸代谢,增加对其他炎症信号的敏感性,可通过膜渗透性甲基丙酮酸补充逆转。
  • IL21减少线粒体-内质网接触位点,增强GSK3β酶功能,导致高代谢状态并放大Treg炎症反应。
  • 甲基丙酮酸和GSK3β药理抑制剂LY2090314逆转IL21诱导的代谢重编程和炎症状态。
  • 体外IL21诱导的Treg代谢基因在人类克罗恩病肠道Tregs中富集。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND & AIMS: Incapacitated regulatory T cells (Tregs) contribute to immune-mediated diseases. Inflammatory Tregs are evident during human inflammatory bowel disease; however, mechanisms driving the development of these cells and their function are not well understood. Therefore, we investigated the role of cellular metabolism in Tregs relevant to gut homeostasis. METHODS: Using human Tregs, we performed mitochondrial ultrastructural studies via electron microscopy and confocal imaging, biochemical and protein analyses using proximity ligation assay, immunoblotting, mass cytometry and fluorescence-activated cell sorting, metabolomics, gene expression analysis, and real-time metabolic profiling utilizing the Seahorse XF analyzer. We used a Crohn's disease single-cell RNA sequencing dataset to infer the therapeutic relevance of targeting metabolic pathways in inflammatory Tregs. We examined the superior functionality of genetically modified Tregs in CD4+ T-cell-induced murine colitis models. RESULTS: Mitochondria-endoplasmic reticulum appositions, known to mediate pyruvate entry into mitochondria via voltage-dependent anion channel 1 (VDAC1), are abundant in Tregs. VDAC1 inhibition perturbed pyruvate metabolism, eliciting sensitization to other inflammatory signals reversible by membrane-permeable methyl pyruvate supplementation. Notably, interleukin (IL) 21 diminished mitochondria-endoplasmic reticulum appositions, resulting in enhanced enzymatic function of glycogen synthase kinase 3 β, a putative negative regulator of VDAC1, and a hypermetabolic state that amplified Treg inflammatory response. Methyl pyruvate and glycogen synthase kinase 3 β pharmacologic inhibitor (LY2090314) reversed IL21-induced metabolic rewiring and inflammatory state. Moreover, IL21-induced metabolic genes in Tregs in vitro were enriched in human Crohn's disease intestinal Tregs. Adoptively transferred Il21r-/- Tregs efficiently rescued murine colitis in contrast to wild-type Tregs. CONCLUSIONS: IL21 triggers metabolic dysfunction associated with Treg inflammatory response. Inhibiting IL21-induced metabolism in Tregs may mitigate CD4+ T-cell-driven chronic intestinal inflammation.

来源:Gastroenterology,查看原文。版权归原作者所有。

引用

  1. Bamidele AO, Mishra SK, Piovezani Ramos G, et al. Interleukin 21 Drives a Hypermetabolic State and CD4+ T-Cell-Associated Pathogenicity in Chronic Intestinal Inflammation. Gastroenterology. 2024. PMID: 38266738. doi:10.1053/j.gastro.2024.01.026

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。